Rebecca Siegel doesn’t usually pay attention to one-year drops in data trends, but the 2.2% decline in overall cancer mortality from 2016 to 2017—driven primarily by lung cancer—seemed too big to ignore.
Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.
